Published in Neurology on February 10, 2016
A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus. J Epidemiol (2017) 0.75
Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nat Rev Neurol (2017) 0.75
Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J Neurol (2016) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
Assessing quality using administrative data. Ann Intern Med (1997) 8.29
Defining comorbidity: implications for understanding health and health services. Ann Fam Med (2009) 5.78
Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol (2003) 4.57
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99
Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology (2008) 2.49
Age at disability milestones in multiple sclerosis. Brain (2006) 2.37
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol (2005) 1.96
Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology (2010) 1.82
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler (2015) 1.80
High frequency of adverse health behaviors in multiple sclerosis. Mult Scler (2008) 1.74
Does multiple sclerosis-associated disability differ between races? Neurology (2006) 1.71
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry (2013) 1.69
Smoking and lung cancer survival: the role of comorbidity and treatment. Chest (2004) 1.67
Obstructive sleep apnea and fatigue in patients with multiple sclerosis. J Clin Sleep Med (2014) 1.59
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology (2010) 1.56
Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis. J Neuroimmunol (2012) 1.46
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler (2012) 1.38
The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med (2014) 1.27
The development, evolution, and modifications of ICD-10: challenges to the international comparability of morbidity data. Med Care (2010) 1.27
A systematic review identifies valid comorbidity indices derived from administrative health data. J Clin Epidemiol (2014) 1.22
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology (2011) 1.22
Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res (2005) 1.21
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler (2015) 1.18
Cigarette smoking and progression in multiple sclerosis. Neurology (2007) 1.15
Smoking and disease progression in multiple sclerosis. Arch Neurol (2009) 1.13
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation (2011) 1.11
Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord (2012) 1.08
Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol (2011) 1.08
Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neurol Sci (2006) 1.04
Normal human aging: factors contributing to cerebral atrophy. J Neurol Sci (1997) 1.02
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran (2012) 1.01
Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med (2009) 1.00
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain (2010) 1.00
A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence. J Neurol Neurosurg Psychiatry (2006) 0.94
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. Mult Scler (2011) 0.94
An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler (2014) 0.90
Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand (2010) 0.90
Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis: an exploratory investigation. Int J MS Care (2013) 0.88
Fatigue, depression and progression in multiple sclerosis. Mult Scler (2008) 0.88
Longitudinal consistency of the relationship between depression symptoms and cognitive functioning in multiple sclerosis. CNS Spectr (2005) 0.86
Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition (2014) 0.85
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol (2008) 0.85
The challenge of comorbidity in clinical trials for multiple sclerosis. Neurology (2016) 0.84
Adverse lipid profile is not associated with relapse risk in MS: results from an observational cohort study. J Neurol Sci (2014) 0.83
Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. Eur J Neurol (2007) 0.83
Social anxiety in a multiple sclerosis clinic population. Mult Scler (2008) 0.81
Uveitis as a prognostic factor in multiple sclerosis. Mult Scler (2014) 0.81
Mental disorders in Mexican patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci (2010) 0.81
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures. Acta Neurol Belg (2013) 0.81
Prevalence of epilepsy in a cohort of patients with multiple sclerosis. Seizure (2013) 0.80
Disability in a community population with MS with and without mental disorders. Int J Psychiatry Med (2012) 0.79
Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis. Mult Scler (2013) 0.79
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study. BMC Neurol (2014) 0.79
Depression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: results from an exploratory telerehabilitation study. NeuroRehabilitation (2003) 0.79
Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol (2015) 0.79
Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional study. Eur J Neurol (2009) 0.78
Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease. Mult Scler (2013) 0.78
The challenge of comorbidity in clinical trials for multiple sclerosis. Neurology (2016) 0.84